FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Wohl

Research Profile

Disorders

Living Beings

Procedures

Chemicals & Drugs

Geographic Areas

North Carolina

Concepts & Ideas

Objects

Prisons

Co-author Network

Publications

TOP 3
Kathryn E Muessig; Jeffrey T Parsons; Emily C Pike; Patrick A Wilson; David A Wohl; Sheana S Bull; Beth Fowler; Sara Legrand; Lisa Hightow-Weidman
Putting Prevention in Their Pockets: Developing Mobile Phone-Based HIV Interventions for Black Men Who Have Sex with Men.
David A Wohl; Suzanne Blevins; Julie Dumond; Joseph J Eron; Michelle Floris-Moore; Michael G Hudgens; Kelley Massengale; Donna Pittard; David Ragan; Amy Richardson; Kendall Walsh; Ruili Wang; Angela D M Kashuba
Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) study.
Prema Menezes; David Rosen; Joseph Sebastian; Joseph J Eron; Nichole Kiziah; David A Wohl; Becky White
Low prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Wohl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kathryn E Muessig; Jeffrey T Parsons; Emily C Pike; Patrick A Wilson; David A Wohl; Sheana S Bull; Beth Fowler; Sara Legrand; Lisa Hightow-Weidman
Putting Prevention in Their Pockets: Developing Mobile Phone-Based HIV Interventions for Black Men Who Have Sex with Men.
AIDS patient care and STDs 2013;27(4):211-22.
2013: David A Wohl; Suzanne Blevins; Julie Dumond; Joseph J Eron; Michelle Floris-Moore; Michael G Hudgens; Kelley Massengale; Donna Pittard; David Ragan; Amy Richardson; Kendall Walsh; Ruili Wang; Angela D M Kashuba
Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) study.
Antimicrobial agents and chemotherapy 2013;57(2):784-8.
2013: Prema Menezes; David Rosen; Joseph Sebastian; Joseph J Eron; Nichole Kiziah; David A Wohl; Becky White
Low prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States.
AIDS research and human retroviruses 2013;29(1):136-41.
2012: David A Wohl
Two epidemics: incarceration and HIV. How the criminal justice system has played a role in the HIV epidemic.
Positively aware : the monthly journal of the Test Positive Aware Network 2012;24(3):17-9.
2012: David L Rosen; David A Wohl; Wizdom P Hammond; Carol E Golin
Disease prevalence and use of health care among a national sample of black and white male state prisoners.
Journal of health care for the poor and underserved 2012;23(1):254-72.
2012: Hao Zhu; Yao Zhang; Decai Zhao; Myron Cohen; Stephen R Cole; Zhihui Dou; Joseph Eron; Zhongfu Liu; Ye Ma; Sonia Napravnik; David A Wohl; Fujie Zhang
Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010.
PloS one 2012;7(6):e39414.
2011: David L Rosen; David A Wohl; Victor J Schoenbach
All-cause and cause-specific mortality among black and white North Carolina state prisoners, 1995-2005.
Annals of epidemiology 2011;21(10):719-26.
2011: Prema Menezes; Joseph J Eron; Peter A Leone; Adaora A Adimora; David A Wohl; William C Miller
Recruitment of HIV/AIDS treatment-naïve patients to clinical trials in the highly active antiretroviral therapy era: influence of gender, sexual orientation and race.
HIV medicine 2011;12(3):183-91.
2011: David A Wohl; Anna Scheyett; Carol E Golin; Becky White; Jeanine Matuszewski; Michael Bowling; Paula Smith; Faye Duffin; David Rosen; Andrew Kaplan; JoAnne Earp
Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial.
AIDS and behavior 2011;15(2):356-64.
2011: David A Wohl; Maria R Khan; Caroline Tisdale; Kathy Norcott; Jesse Duncan; Andrew M Kaplan; Sharon Weir
Locating the places people meet new sexual partners in a southern US city to inform HIV/STI prevention and testing efforts.
AIDS and behavior 2011;15(2):283-91.
2011: Prema Menezes; William C Miller; William C Miller; David A Wohl; Adaora A Adimora; Peter A Leone; Joseph J Eron
Does HAART efficacy translate to effectiveness? Evidence for a trial effect.
PloS one 2011;6(7):e21824.
2010: David A Wohl
Deconstructing most recent antiretroviral recommendations.
Current HIV/AIDS reports 2010;7(2):77-84.
2010: Anna Scheyett; Sharon Parker; Carol E Golin; Becky White; Carrie Pettus Davis; David A Wohl
HIV-infected prison inmates: depression and implications for release back to communities.
AIDS and behavior 2010;14(2):300-7.
2009: David L Rosen; Victor J Schoenbach; David A Wohl; Becky White; Paul W. Stewart; Carol E Golin
An evaluation of HIV testing among inmates in the North Carolina prison system.
American journal of public health 2009;99 Suppl 2():S452-9.
2009: David L Rosen; Victor J Schoenbach; David A Wohl; Becky White; Paul W. Stewart; Carol E Golin
Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system.
American journal of public health 2009;99(6):1123-30.
2009: David A Wohl; M A Kendall; J Andersen; C Crumpacker; S A Spector; J Feinberg; B Alston-Smith; S Owens; S Chafey; M Marco; S Maxwell; N Lurain; D Jabs; C Benson; P Keiser; M A Jacobson
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.
HIV clinical trials 2009;10(3):143-52.
2009: Charles B Hicks; Edwin DeJesus; Louis M Sloan; Michael G Sension; David A Wohl; Qiming Liao; Lisa L Ross; Gary E Pakes; Keith A Pappa; Charles Tracey Lancaster
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
AIDS research and human retroviruses 2009;25(4):395-403.
2008: David L Rosen; Victor J Schoenbach; David A Wohl
All-cause and cause-specific mortality among men released from state prison, 1980-2005.
American journal of public health 2008;98(12):2278-84.
2008: David A Wohl; David Waters; Ross J Simpson; Susan Richard; Amanda Schnell; Sonia Napravnik; Jessica Keys; Joseph J Eron; Priscilla Y Hsue
Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1105-8.
2008: David A Wohl; Todd T Brown
Management of morphologic changes associated with antiretroviral use in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2008;49 Suppl 2():S93-S100.
2008: Priscilla Y Hsue; Kathleen Squires; Ann F Bolger; Bernadette Capili; George Mensah; Zelalem Temesgen; Christine A Wanke; David A Wohl
Screening and assessment of coronary heart disease in HIV-infected patients.
Circulation 2008;118(2):e41-7.
2008: Maria R Khan; William C Miller; Victor J Schoenbach; Sharon Weir; Jay S Kaufman; David A Wohl; Adaora A Adimora
Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina.
Annals of epidemiology 2008;18(5):403-10.
2008: David A Wohl; Rebecca Scherzer; Steven Heymsfield; Michael Simberkoff; Stephen Sidney; Peter Bacchetti; Carl Grunfeld
The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men.
Journal of acquired immune deficiency syndromes (1999) 2008;48(1):44-52.
2008: John G Gerber; Douglas W Kitch; Carl J Fichtenbaum; Robert A Zackin; Stéphannie Charles; Evelyn Hogg; Edward P Acosta; Elizabeth Connick; David A Wohl; E Milu Kojic; Constance A Benson; Judith A Aberg
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.
Journal of acquired immune deficiency syndromes (1999) 2008;47(4):459-66.
2008: Maria R Khan; David A Wohl; Sharon Weir; Adaora A Adimora; Caroline Moseley; Kathy Norcott; Jesse Duncan; Jay S Kaufman; William C Miller
Incarceration and risky sexual partnerships in a southern US city.
Journal of urban health : bulletin of the New York Academy of Medicine 2008;85(1):100-13.
2007: Grace A McComsey; Michelle A Kendall; Pablo Tebas; Susan Swindells; Evelyn Hogg; Beverly Alston-Smith; Carol Suckow; Geetha Gopalakrishnan; Constance Benson; David A Wohl
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
AIDS (London, England) 2007;21(18):2473-82.
2007: David A Wohl
HIV treatment series. Metabolic complications myths. Some misunderstandings about treatment.
Positively aware : the monthly journal of the Test Positive Aware Network 2007;18(6):25-8.
2007: David A Wohl
Considering metabolic issues when initiating HIV therapy.
Current HIV/AIDS reports 2007;4(3):119-25.
2007: David A Wohl
Editorial comment: fish oil to keep the cardiologist away?
The AIDS reader 2007;17(7):371.
2007: Lynda A Szczech; Carl Grunfeld; Rebecca Scherzer; Jesse Canchola; Charles van der Horst; Stephen Sidney; David A Wohl; Michael G Shlipak
Microalbuminuria in HIV infection.
AIDS (London, England) 2007;21(8):1003-9.
2007: Sonia Napravnik; Jessica R Keys; E Byrd Quinlivan; David A Wohl; Oksana V Mikeal; Joseph J Eron
Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
AIDS (London, England) 2007;21(7):825-34.
2007: Charles Hultman; Lindsee E McPhail; Jeffrey H Donaldson; David A Wohl
Surgical management of HIV-associated lipodystrophy: role of ultrasonic-assisted liposuction and suction-assisted lipectomy in the treatment of lipohypertrophy.
Annals of plastic surgery 2007;58(3):255-63.
2006: David A Wohl; Grace A McComsey; Pablo Tebas; Todd T Brown; Marshall J Glesby; D Reeds; Cecilia M Shikuma; K Mulligan; M Dube; David A Wininger; Jeannie S Huang; Manuel Revuelta; Judith Currier; Susan Swindells; Carl J Fichtenbaum; M Basar; M Tungsiripat; W Meyer; J Weihe; Christine Wanke
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(5):645-53.
2006: Becky White; David A Wohl; Ron Hays; Carol E Golin; Honghu Liu; C Nichole Kiziah; Gregory Simpson; Andrew H Kaplan
A pilot study of health beliefs and attitudes concerning measures of antiretroviral adherence among prisoners receiving directly observed antiretroviral therapy.
AIDS patient care and STDs 2006;20(6):408-17.
2006: David A Wohl; David Rosen; Andrew H Kaplan
HIV and incarceration: dual epidemics.
The AIDS reader 2006;16(5):247-50, 257-60.
2006: Sam M Mbulaiteye; Jonnae O Atkinson; Denise Whitby; David A Wohl; Joel E Gallant; Scott Royal; James J Goedert; Charles S Rabkin
Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(4):442-9.
2006: Andrea S Foulkes; David A Wohl; Ian Frank; Elaine Puleo; Stephanie Restine; Megan L Wolfe; Michael P Dube; Pablo Tebas; Muredach P Reilly
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.
PLoS medicine 2006;3(3):e52.
2006: Becky L Stephenson; David A Wohl; Rosemary G McKaig; Carol E Golin; Lara Shain; Monica Adamian; Cathy Emrick; Ronald P Strauss; Catherine Fogel; Andrew H Kaplan
Sexual behaviours of HIV-seropositive men and women following release from prison.
International journal of STD & AIDS 2006;17(2):103-8.
2005: David A Wohl; Hsiao-Chuan Tien; Marjorie Busby; Catherine Cunningham; Beth Macintosh; Sonia Napravnik; Elisheva Danan; Kimberly Donovan; Mina Hossenipour; Ross J Simpson
Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1498-504.
2005: David A Wohl
Editorial comment: correcting facial lipoatrophy has little to do with vanity.
The AIDS reader 2005;15(7):372.
2005: Eric Nawar; Sam M Mbulaiteye; Joel E Gallant; David A Wohl; Marianne Ardini; Tabitha Hendershot; James J Goedert; Charles S Rabkin
Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS.
International journal of cancer. Journal international du cancer 2005;115(2):296-300.
2005: David A Wohl
Body shape, lipid, and cardiovascular complications of HIV therapy.
Current HIV/AIDS reports 2005;2(2):74-82.
2005: David A Wohl; Michelle A Kendall; Susan Owens; G Holland; Mostafa Nokta; S A Spector; R Schrier; Susan A Fiscus; M Davis; Mark A Jacobson; Judith S Currier; K Squires; Beverly Alston-Smith; J Andersen; W R Freeman; M Higgins; Francesca J Torriani
The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
HIV clinical trials 2005;6(3):136-46.
2005: David A Wohl; Donglin Zeng; Paul W. Stewart; Nicolas Glomb; Timothy Alcorn; Suzanne Jones; Jean Handy; Susan A Fiscus; Adriana Weinberg; Deepthiman Gowda; Charles van der Horst
Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
Journal of acquired immune deficiency syndromes (1999) 2005;38(5):538-44.
2005: Becky L Stephenson; David A Wohl; Carol E Golin; Hsiao-Chuan Tien; Paul W. Stewart; Andrew H Kaplan
Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.
Public health reports (Washington, D.C. : 1974) 2005;120(1):84-8.
2004: Adriana Weinberg; Renee D Jesser; Charles L Edelstein; Jerome R Bill; David A Wohl
Excess apoptosis of mononuclear cells contributes to the depressed cytomegalovirus-specific immunity in HIV-infected patients on HAART.
Virology 2004;330(1):313-21.
2004: David L Rosen; Carol E Golin; Victor J Schoenbach; Becky L Stephenson; David A Wohl; Brett Gurkin; Andrew H Kaplan
Availability of and access to medical services among HIV-infected inmates incarcerated in North Carolina county jails.
Journal of health care for the poor and underserved 2004;15(3):413-25.
2004: Lisa Hightow-Weidman; William C Miller; Peter A Leone; David A Wohl; Marlene Smurzynski; Andrew H Kaplan
Predictors of repeat testing and HIV seroconversion in a sexually transmitted disease clinic population.
Sexually transmitted diseases 2004;31(8):455-9.
2004: David A Wohl
Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2004;12(3):89-93.
2004: David A Wohl; Christopher D Pilcher; Scott Evans; Manuel Revuelta; Grace A McComsey; Yijun Yang; Robert Zackin; Beverly Alston; Stacey Welch; Michael Basar; Angela D M Kashuba; Pualani Kondo; Ana Martinez; Jeffrey Giardini; Joseph Quinn; Melvin Littles; Harry Wingfield; Susan L Koletar
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity.
Journal of acquired immune deficiency syndromes (1999) 2004;35(3):274-8.
2003: Adriana Weinberg; David A Wohl; Samantha MaWhinney; Rachel J Barrett; Darby G Brown; Nick Glomb; Charles van der Horst
Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy.
AIDS (London, England) 2003;17(17):2445-50.
2003: David A Wohl; Becky L Stephenson; Carol E Golin; C Nichole Kiziah; David Rosen; Bich Ngo; Honghu Liu; Andrew H Kaplan
Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(12):1572-6.
2003: Lisa Hightow-Weidman; William C Miller; Peter A Leone; David A Wohl; Marlene Smurzynski; Andrew H Kaplan
Failure to return for HIV posttest counseling in an STD clinic population.
AIDS education and prevention : official publication of the International Society for AIDS Education 2003;15(3):282-90.
2002: David A Wohl; Francesca T Aweeka; John L Schmitz; Roger Pomerantz; Deborah Weng Cherng; John Spritzler; Lawrence Fox; David Simpson; Dawn Bell; M K Holohan; Steven Thomas; Wayne Robinson; Gilla Kaplan; Hedy Teppler
Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.
The Journal of infectious diseases 2002;185(9):1359-63.
2002: Christopher D Pilcher; David A Wohl; Charles B Hicks
Diagnosing primary HIV infection.
Annals of internal medicine 2002;136(6):488-9; author reply 488-9.
2001: Adriana Weinberg; David A Wohl; R J Barrett; Charles van der Horst
Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
The Journal of infectious diseases 2001;184(6):707-12.
2001: Jeffrey M Jacobson; John Greenspan; John Spritzler; Lawrence Fox; John L Fahey; J Brooks Jackson; Miriam Chernoff; David A Wohl; J J Pulvirenti; Thomas Hooton; Cecilia M Shikuma
Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
The Journal of infectious diseases 2001;183(2):343-346.
2000: Adriana Weinberg; David A Wohl; Darby G Brown; Gregory B Pott; L Zhang; M G Ray; Charles van der Horst
Effect of cryopreservation on measurement of cytomegalovirus-specific cellular immune responses in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2000;25(2):109-14.
2000: David A Wohl; S Pedersen; Charles van der Horst
Routine ophthalmologic screening for cytomegalovirus retinitis in patients with AIDS.
Journal of acquired immune deficiency syndromes (1999) 2000;23(5):438-9.
2000: R B Qaqish; E Fisher; John C Rublein; David A Wohl
HIV-associated lipodystrophy syndrome.
Pharmacotherapy 2000;20(1):13-22.
1999: Jeffrey M Jacobson; John Spritzler; Lawrence Fox; John L Fahey; J Brooks Jackson; Miriam Chernoff; David A Wohl; Albert W Wu; Thomas Hooton; Beverly E Sha; Cecilia M Shikuma; Laurie MacPhail; David M Simpson; Carol B Trapnell; N Basgoz
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
The Journal of infectious diseases 1999;180(1):61-7.
1999: SR Virata; JA Kylstra; JC Brown; David A Wohl; Myron S Cohen
Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(5):1177-8.
1997: Jennifer Webster-Cyriaque; Rachel H Edwards; E Byrd Quinlivan; Lauren Patton; David A Wohl; Nancy Raab-Traub
Epstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions.
The Journal of infectious diseases 1997;175(6):1324-32.
1997: Jeffrey M Jacobson; John Greenspan; John Spritzler; N Ketter; John L Fahey; J Brooks Jackson; Lawrence Fox; Miriam Chernoff; Albert W Wu; Laurie MacPhail; G J Vasquez; David A Wohl
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
The New England journal of medicine 1997;336(21):1487-93.